Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Hans Theodor Eich; Volker Diehl; Helen Görgen; Thomas Pabst; Jana Markova; Jürgen Debus; Anthony Ho; Bernd Dörken; Andreas Rank; Anca-Ligia Grosu; Thomas Wiegel; Johann Hinrich Karstens; Richard Greil; Normann Willich; Heinz Schmidberger; Hartmut Döhner; Peter Borchmann; Hans-Konrad Müller-Hermelink; Rolf-Peter Müller; Andreas Engert

doi:10.1200/JCO.2010.29.8018

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Hans Theodor Eich, Volker Diehl, Helen Görgen, Thomas Pabst, Jana Markova, Jürgen Debus, Anthony Ho, Bernd Dörken, Andreas Rank, Anca-Ligia Grosu, Thomas Wiegel, Johann Hinrich Karstens, Richard Greil (Co-author), Normann Willich, Heinz Schmidberger, Hartmut Döhner, Peter Borchmann, Hans-Konrad Müller-Hermelink, Rolf-Peter Müller, Andreas Engert

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

320 Citations (Web of Science)

Original language	English
Pages (from-to)	4199-4206
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	28
Issue number	27
DOIs	https://doi.org/10.1200/JCO.2010.29.8018
Publication status	Published - 2010

Keywords

POSITRON-EMISSION-TOMOGRAPHY
INTERNATIONAL PROGNOSTIC SCORE
NODE RADIOTHERAPY
STAGE-I
DISEASE
CYCLES
PROGRESSION
RADIATION
SUPERIOR
THERAPY

Access to Document

10.1200/JCO.2010.29.8018

Cite this

Eich, H. T., Diehl, V., Görgen, H., Pabst, T., Markova, J., Debus, J., Ho, A., Dörken, B., Rank, A., Grosu, A.-L., Wiegel, T., Karstens, J. H., Greil, R., Willich, N., Schmidberger, H., Döhner, H., Borchmann, P., Müller-Hermelink, H.-K., Müller, R.-P., & Engert, A. (2010). Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. JOURNAL OF CLINICAL ONCOLOGY , 28(27), 4199-4206. https://doi.org/10.1200/JCO.2010.29.8018

Eich, Hans Theodor ; Diehl, Volker ; Görgen, Helen et al. / Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. In: JOURNAL OF CLINICAL ONCOLOGY 2010 ; Vol. 28, No. 27. pp. 4199-4206.

@article{2f62ec57584a46f8817323133d36ac87,

title = "Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin{"}s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, INTERNATIONAL PROGNOSTIC SCORE, NODE RADIOTHERAPY, STAGE-I, DISEASE, CYCLES, PROGRESSION, RADIATION, SUPERIOR, THERAPY",

author = "Eich, {Hans Theodor} and Volker Diehl and Helen G{\"o}rgen and Thomas Pabst and Jana Markova and J{\"u}rgen Debus and Anthony Ho and Bernd D{\"o}rken and Andreas Rank and Anca-Ligia Grosu and Thomas Wiegel and Karstens, {Johann Hinrich} and Richard Greil and Normann Willich and Heinz Schmidberger and Hartmut D{\"o}hner and Peter Borchmann and Hans-Konrad M{\"u}ller-Hermelink and Rolf-Peter M{\"u}ller and Andreas Engert",

year = "2010",

doi = "10.1200/JCO.2010.29.8018",

language = "English",

volume = "28",

pages = "4199--4206",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "27",

}

Eich, HT, Diehl, V, Görgen, H, Pabst, T, Markova, J, Debus, J, Ho, A, Dörken, B, Rank, A, Grosu, A-L, Wiegel, T, Karstens, JH, Greil, R, Willich, N, Schmidberger, H, Döhner, H, Borchmann, P, Müller-Hermelink, H-K, Müller, R-P & Engert, A 2010, 'Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.', JOURNAL OF CLINICAL ONCOLOGY , vol. 28, no. 27, pp. 4199-4206. https://doi.org/10.1200/JCO.2010.29.8018

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. / Eich, Hans Theodor; Diehl, Volker; Görgen, Helen et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 28, No. 27, 2010, p. 4199-4206.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

AU - Eich, Hans Theodor

AU - Diehl, Volker

AU - Görgen, Helen

AU - Pabst, Thomas

AU - Markova, Jana

AU - Debus, Jürgen

AU - Ho, Anthony

AU - Dörken, Bernd

AU - Rank, Andreas

AU - Grosu, Anca-Ligia

AU - Wiegel, Thomas

AU - Karstens, Johann Hinrich

AU - Greil, Richard

AU - Willich, Normann

AU - Schmidberger, Heinz

AU - Döhner, Hartmut

AU - Borchmann, Peter

AU - Müller-Hermelink, Hans-Konrad

AU - Müller, Rolf-Peter

AU - Engert, Andreas

PY - 2010

Y1 - 2010

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - INTERNATIONAL PROGNOSTIC SCORE

KW - NODE RADIOTHERAPY

KW - STAGE-I

KW - DISEASE

KW - CYCLES

KW - PROGRESSION

KW - RADIATION

KW - SUPERIOR

KW - THERAPY

U2 - 10.1200/JCO.2010.29.8018

DO - 10.1200/JCO.2010.29.8018

M3 - Original Article

C2 - 20713848

SN - 0732-183X

VL - 28

SP - 4199

EP - 4206

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 27

ER -

Eich HT, Diehl V, Görgen H, Pabst T, Markova J, Debus J et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. JOURNAL OF CLINICAL ONCOLOGY . 2010;28(27):4199-4206. doi: 10.1200/JCO.2010.29.8018